| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/30/2004 | US20040265303 Anti-CCR2 antibodies and methods of use therefor |
| 12/30/2004 | US20040265300 Targeting cancer cell; induction or prevention of apoptosis in eukaryotic cells; a fusion peptide contains a viral apoptotic peptide and an antibody fragment; recombinant host cell comprising the vector, encoding chimeric polypeptide; bioassay monitoring apoptosis activity; drug target |
| 12/30/2004 | US20040265290 Lactic acid bacteria as agents for treating and preventing allergy |
| 12/30/2004 | US20040265287 Myocardial grafts and cellular compositions useful for same |
| 12/30/2004 | US20040265284 Methods for enhanced virus-mediated DNA transfer using molecules with virus-and cell-binding domains |
| 12/30/2004 | US20040265278 Moraxella catarrhalis antigen, corresponding gene and uses thereof |
| 12/30/2004 | US20040265277 Agents for treating malignant diseases using the protein YB-1 |
| 12/30/2004 | US20040265276 Medicinal combination useful for in vivo exogenic transfection and expression |
| 12/30/2004 | US20040265273 gene therapy; nucleic acid sequence encoding an amino terminal fragment of urokinase that comprises and epidermal growth factor-like domain; antimetastasis; murine urokinase ATF expressed by tumor cells in an athymic murine model unexpectedly effectively inhibits tumorigenicity |
| 12/30/2004 | US20040265272 Mammalian cell-infecting virus vector encoding epitope-bound beta2m and utilization thereof |
| 12/30/2004 | US20040265271 Reovirus for the treatment of neoplasia |
| 12/30/2004 | US20040265269 Cysteine variants of granulocyte colony-stimulating factor |
| 12/30/2004 | US20040265229 Urokinase plasminogen activator receptor as a target for diagnosis of metastases |
| 12/30/2004 | US20040263543 Production method and production apparatus of probe carrier |
| 12/30/2004 | US20040261799 Intrauterine device, method of making such a device and method for putting active elements within the uterine cavity |
| 12/30/2004 | DE20221079U1 New expression vector for producing annexin V, useful as anticoagulant, includes kanamycin resistance gene, also Escherichia coli containing the vector |
| 12/30/2004 | DE19912799B4 Superparamagnetisches Adsorptionsmaterial und seine Verwendung Superparamagnetic adsorption and its use |
| 12/30/2004 | DE10324447A1 Generierung künstlicher Bindungsproteine auf der Grundlage von Ubiquitin Generation of artificial binding proteins on the basis of ubiquitin |
| 12/29/2004 | WO2004113867A2 Exon analysis |
| 12/29/2004 | WO2004113575A1 Plasmid-free clone of e. coli strain dsm 6601 |
| 12/29/2004 | WO2004113573A2 Methods and compositions for analysis of plant gene function |
| 12/29/2004 | WO2004113572A1 Composition for screening anti-hypertension drug comprising mammal tctp gene or its protein product, and method for screening anti-hypertension drug using said composition |
| 12/29/2004 | WO2004113570A2 Genotype test for dogs |
| 12/29/2004 | WO2004113566A2 Disease related protein network |
| 12/29/2004 | WO2004113562A1 Method for assaying lkb1 phosphorylation activity |
| 12/29/2004 | WO2004113552A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 12/29/2004 | WO2004113550A1 Process for producing l-glutamic acid |
| 12/29/2004 | WO2004113547A2 Potent combinations of mrna transport elements |
| 12/29/2004 | WO2004113546A2 CASTANEA SATIVA MILL. GENES CODIFYING FOR ALLENE OXIDE CYCLASE, CYSTATIN, β-1,3-GLUCANASE AND THAUMATIN-LIKE PROTEIN AND THEIR USE |
| 12/29/2004 | WO2004113545A1 Method for biosynthesizing the serotonin derivatives in plants |
| 12/29/2004 | WO2004113544A1 Limit dextrinase inhibitor promoter |
| 12/29/2004 | WO2004113543A1 Plant lipase |
| 12/29/2004 | WO2004113542A1 Methods and means for delaying seed shattering in plants |
| 12/29/2004 | WO2004113541A2 Plant transcriptional activator and uses thereof |
| 12/29/2004 | WO2004113540A1 Expression of heterologous protein |
| 12/29/2004 | WO2004113539A2 Method for producing a recombinant protein of interest and protein thus produced |
| 12/29/2004 | WO2004113538A1 Gene coding mannanase and recombinant mannanase expressed from transformant thereof |
| 12/29/2004 | WO2004113537A1 Method of improving fertility of hybrid plant comprising locating fertility restoration genes on plural loci |
| 12/29/2004 | WO2004113536A1 Ryegrass pollen-specific promoters and expression constructs |
| 12/29/2004 | WO2004113535A1 Synuclein mutant having anticoagulant effect |
| 12/29/2004 | WO2004113534A1 Method for producing a synthetic gene or other dna sequence |
| 12/29/2004 | WO2004113531A1 Conditioned autophagy-deficient animal and disease model animal |
| 12/29/2004 | WO2004113529A1 Method of detecting reaction between dna and dna binding proteins |
| 12/29/2004 | WO2004113528A2 Isoforms of elf-5a: senescence-induced elf5a; wounding-induced elf-5a; growth elf-5a; and dhs |
| 12/29/2004 | WO2004113527A1 Gene involved in abscisic acid inactivation |
| 12/29/2004 | WO2004113526A1 Method of preparing gene expression profile |
| 12/29/2004 | WO2004113523A1 Granzyme b/golgin-160 interaction inhibitor |
| 12/29/2004 | WO2004113521A1 New biological entities and the use thereof |
| 12/29/2004 | WO2004113519A2 Alcohol dehydrogenase sequences useful for developing compounds for the prevention and/or treatment of metabolic diseases |
| 12/29/2004 | WO2004113517A2 IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA |
| 12/29/2004 | WO2004113508A1 Production of cephalosporin intermediates in penicillium chrysogenum |
| 12/29/2004 | WO2004113504A2 High level production of arbutin in green plants and microbes |
| 12/29/2004 | WO2004113501A2 Methods and compositions relating to lipid accumulation |
| 12/29/2004 | WO2004113500A2 B7s1: an immune modulator |
| 12/29/2004 | WO2004113499A2 Modulation of flowering time by the pft1 locus |
| 12/29/2004 | WO2004113496A2 Double stranded compositions comprising a 3’-endo modified strand for use in gene modulation |
| 12/29/2004 | WO2004113495A2 Rna-based transcriptional regulators |
| 12/29/2004 | WO2004113494A2 Methods for producing preparations of recombinant aav virions substantially free of empty capsids |
| 12/29/2004 | WO2004113493A2 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
| 12/29/2004 | WO2004113388A2 Anti alpha - folate - receptor - tetramer antibodies |
| 12/29/2004 | WO2004113385A1 Protein c propeptide variants |
| 12/29/2004 | WO2004113376A1 Modified oleosins |
| 12/29/2004 | WO2004113372A1 MODIFIED BORDETELLA ADENYLATE CYCLASE COMPRISING OR LACKING CD11b/CD18 INTERACTION DOMAIN AND USES THEREOF |
| 12/29/2004 | WO2004112831A2 High titer recombinant influenza viruses for vaccines and gene therapy |
| 12/29/2004 | WO2004112823A1 Proton-sensing g-protein coupled receptors and dna sequences thereof |
| 12/29/2004 | WO2004112727A2 Aav virions with decreased immunoreactivity and uses therefor |
| 12/29/2004 | WO2004112721A2 Prevention or treatment of deficits that arise in connection with diseases of, or injuries to, the nervous system |
| 12/29/2004 | WO2004112575A2 Gene amplification and overexpression in cancer |
| 12/29/2004 | WO2004112473A1 Novel animal model for epilepsy |
| 12/29/2004 | WO2004112468A1 Plant limit dextrinase inhibitor |
| 12/29/2004 | WO2004101798A3 Method for the preparation of transgenic plants characterised by geminivirus lasting resistance |
| 12/29/2004 | WO2004099418A8 Fused protein |
| 12/29/2004 | WO2004099244A3 Immunogenic human tnf alpha analogues with reduced cytotoxicity and methods of their preparation |
| 12/29/2004 | WO2004096999A3 In vitro translation system |
| 12/29/2004 | WO2004096124A3 Compositions and methods for the diagnosis and treatment of tumor |
| 12/29/2004 | WO2004093790A3 Yeast ectopically expressing abnormally processed proteins and uses therefor |
| 12/29/2004 | WO2004091288A3 Correcting mitotic spindle defects in somatic cell nuclear transfer |
| 12/29/2004 | WO2004090123A3 Δ-4 desaturases from euglena gracilis, expressing plants, and oils containing pufa |
| 12/29/2004 | WO2004084942A3 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18) |
| 12/29/2004 | WO2004083461A9 Recovery of dna |
| 12/29/2004 | WO2004083248A9 Antibodies to igf-i receptor for the treatment of cancers |
| 12/29/2004 | WO2004078097A3 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer |
| 12/29/2004 | WO2004074458A3 N-acetylglucosaminyltransferase iii expression in lower eukaryotes |
| 12/29/2004 | WO2004072244A3 Polymerase-based protocols for generating chimeric oligonucleotides |
| 12/29/2004 | WO2004063328A3 Method for cloning and expression of bsrgi restriction endonuclease and bsrgi methyltransferase in e. coli |
| 12/29/2004 | WO2004062350A3 Methods and compositions for producing male sterile plants |
| 12/29/2004 | WO2004046332A3 Amplified genes involved in cancer |
| 12/29/2004 | WO2004043886A3 Production of pharmaceutically active proteins in sprouted seedlings |
| 12/29/2004 | WO2004042083A3 Nucleic acid ligands and uses therefor |
| 12/29/2004 | WO2004042036A3 Process for expression and secretion of proteins by the non-conventional yeast zygosaccharomyces bailii |
| 12/29/2004 | WO2004042004A3 Mouse model for autoimmune disorders |
| 12/29/2004 | WO2004039309A3 Dc-sign isoforms, related compositions and methods for their use in disease therapy |
| 12/29/2004 | WO2004033664A3 Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 12/29/2004 | WO2004016803A3 Method of enhancing cd4+ t cell responses |
| 12/29/2004 | WO2004015072A3 Mrbs as modifiers of the rb pathway and methods of use |
| 12/29/2004 | WO2004013276A3 Novel tricistronic vectors and uses therefor |
| 12/29/2004 | WO2004005481A3 Methods for identifying modulators of mda-7 mediated apoptosis |
| 12/29/2004 | WO2003093797A3 Polynucleotides for the detection and quantification of hepatitis b virus nucleic acids |
| 12/29/2004 | WO2003089621A8 Promoter and plasmid system for genetic engineering |
| 12/29/2004 | WO2003086453A8 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis |